Reglagene, a Tucson-based start-up therapeutics company, specializes in developing brain-penetrant medicines for brain cancer treatment. To secure funding for advancing their product through FDA approval, Reglagene partnered with NüPOINT Marketing for a strategic campaign targeting investors at an upcoming biotech convention.
With just three weeks to develop and implement a comprehensive marketing strategy, both the timeline and budget was tight. Moreover, competition for investor attention at the international convention was intense with numerous startups seeking funding.
Reglagene’s BIO Conference presentation was standing room only, with digital ads generating nearly 40,000 impressions. Post-conference email campaigns garnered over 12,500 views and 1,750 clicks to the website. Most importantly, Reglagene secured its first outside investment from an angel group, providing critical funding for FDA-required studies.
NüPOINT’s campaign positioned Reglagene for future growth, laying the groundwork for media relations and ongoing communications as the company prepares to enter human clinical trials.